Back to Search
Start Over
AstraZeneca Pharmaceuticals LP
- Source :
- Applied Clinical Trials. September 2001, Vol. 10 Issue 9, p20, 1 p.
- Publication Year :
- 2001
-
Abstract
- AstraZeneca Pharmaceuticals LP (Wilmington, DE) announced the results of a randomized, double-blind, Phase 3 study comparing Exanta (ximelagatran, formerly known as H376/95) with warfarin for the prevention of deep vein [...]
- Subjects :
- AstraZeneca Pharmaceuticals L.P. -- Research
Exanta (Medication) -- Testing -- Evaluation
Pulmonary embolism -- Drug therapy -- Research
Pharmaceutical research -- Evaluation -- Research
Venous thrombosis -- Drug therapy -- Research
General interest
Health
Testing
Drug therapy
Evaluation
Research
Subjects
Details
- Language :
- English
- ISSN :
- 10648542
- Volume :
- 10
- Issue :
- 9
- Database :
- Gale General OneFile
- Journal :
- Applied Clinical Trials
- Publication Type :
- Periodical
- Accession number :
- edsgcl.80223093